Autoimmunity, Insulin-Resistance, Non-Classic Adrenal Hyperplasia, and Vitamin D 

Sacerdote, A. Adrenal Hyperandrogenemia in IDDM. Program and Abstracts, 77th Annual Meeting of The Endocrine Society: 545, 1995 (poster presentation).

Sacerdote, A. Adrenal Hyperandrogenemia in Graves’ Disease. Program and Abstracts, Tenth International Congress of Endocrinology II: 1000, 1996 (poster presentation).

Sacerdote, A. Adrenal Hyperandrogenemia in Hashimoto’s Thyroiditis. Program and Abstracts, Tenth International Congress of Endocrinology II: 1000, 1996 (poster presentation).

Sacerdote, A. Vitiligo Is Associated with Adrenal Hyperandrogenemia. 66 Program and Abstracts, 80th Annual Meeting of The Endocrine Society: 199, 1998 (poster presentation).

Sacerdote, A. and Li, Y. Adrenal Hyperandrogenemia in Psoriasis. Program and Abstracts, 79th Annual Meeting of The Endocrine Society: 310, 1997 (poster presentation).

Sacerdote AS, Bahtiyar G, Mejía J. Rheumatoid arthritis is associated with non-classical adrenal hyperplasia. Program and Abstracts, Endo 2007, 89th Annual Meeting of The Endocrine Society 672, 2007 (poster presentation).

Sacerdote AS. Adrenal androgens and NIDDM. Diabetes Care 1995 Feb; 18(2): 278-9.

Itariu BK, Stulnig TM. Autoimmune aspects of type 2 diabetes mellitus - a mini-review. Gerontology 2014; 60(3): 189-96. https://doi.org/10.1159/000356747

Olga Jachimowicz-Duda, Jacka Kaczmarskiego. The Relationship between Interleukin-34 Level and Selected Biochemical and Clinical Parameters in Patients with Type 2 Diabetes. Poster 12, Autoimmunity in 2017; Where Are We Now? Brooklyn, NY April 28, 2017.

Speiser PW, Serrat J, New MI, Gertner JM Insulin insensitivity in adrenal hyperplasia due to nonclassical steroid 21-hydroxylase deficiency. J Clin Endocrinol Metab 1992 Dec; 75(6): 1421-4.

Saygili F, Oge A, Yilmaz C. Hyperinsulinemia and insulin insensitivity in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency: the relationship between serum leptin levels and chronic hyperinsulinemia. Horm Res 2005; 63(6): 270-4.

Atabek ME, Kurtoğlu S, Keskin M. Female pseudohermaphroditism due to classical 21-hydroxylase deficiency and insulin resistance in a girl with Turner syndrome. Turk J Pediatr 2005; 47(2): 176-9.

Charmandari E, Weise M, Bornstein SR, Eisenhofer G, Keil MF, Chrousos GP, Merke DP. Children with classic congenital adrenal hyperplasia have elevated serum leptin concentrations and insulin resistance: potential clinical implications. J Clin Endocrinol Metab 2002; 87(5): 2114-20. https://doi.org/10.1210/jcem.87.5.8456

Nokoff NJ, Rewers M, Cree Green M. The interplay of autoimmunity and insulin resistance in type 1 diabetes. Discov Med 2012; 13(69): 115-22.

Pozzilli P1, Guglielmi C, Caprio S, Buzzetti R. Obesity, autoimmunity, and double diabetes in youth. Diabetes Care 2011; 34 Suppl 2: S166-70.

Arora S, Sinha K, Kolte S1, Mandal A. Endocrinal and autoimmune linkage: Evidences from a controlled study of subjects with polycystic ovarian syndrome. J Hum Reprod Sci 2016 Jan-Mar; 9(1): 18-22.

Gyldenløve M, Storgaard H2, Holst JJ3, Vilsbøll T2, Knop FK4, Skov L. Patients with psoriasis are insulin resistant. J Am Acad Dermatol 2015; 72(4): 599-605. https://doi.org/10.1016/j.jaad.2015.01.004

Siemińska L, Foltyn W, Głogowska-Szeląg J, Kajdaniuk D, Marek B, Nowak M, Walczak K, Kos-Kudła B. Relationships between adiponectin, sex hormone binding globulin and insulin resistance in hyperthyroid Graves' disease women. Endokrynol Pol 2013; 64(1): 26-9.

Festi D, Schiumerini R, Eusebi LH, Marasco G, Taddia M, Colecchia A. Gut microbiota and metabolic syndrome. World J Gastroenterol 2014 20(43): 16079-16094.

Borst SE. The role of TNF-alpha in insulin resistance. Endocrine 2004; 23(2-3): 177-82.

Feldmann M, Maini RN. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Annu Rev Immunol 2001; 19: 163-96.

Santos FM, Telles RW, Lanna CC, Teixeira AL Jr4, Miranda AS, Rocha NP, Ribeiro AL. Adipokines, tumor necrosis factor and its receptors in female patients with systemic lupus erythematosus. Lupus 2016 Jun 30. pii: 0961203316646463.

Campanati A, Orciani M2, Lazzarini R, Ganzetti G, Consales V, Sorgentoni G, Di Primio R, Offidani A. TNF-α inhibitors reduce the pathological Th1 -Th17 /Th2 imbalance in Cutaneous Mesenchymal Stem Cells of psoriasis patients. Exp Dermatol 2016 Jul 4. https://doi.org/10.1111/exd.13139

Heilig B, Fiehn C, Brockhaus M, Gallati H, Pezzutto A, Hunstein W. Evaluation of soluble tumor necrosis factor (TNF) receptors and TNF receptor antibodies in patients with systemic lupus erythematodes, progressive systemic sclerosis, and mixed connective tissue disease. J Clin Immunol 1993; 13(5): 321-8. https://doi.org/10.1007/BF00920240

Durães C, Moreira CS, Alvelos I, Mendes A, Santos LR, Machado JC, Melo M, Esteves C, Neves C, Sobrinho-Simões M, Soares P. Polymorphisms in the TNFA and IL6 genes represent risk factors for autoimmune thyroid disease. PLoS One 2014 Aug 15; 9(8): e105492.

Díez JJ, Hernanz A, Medina S, Bayón C, Iglesias P. Serum concentrations of tumour necrosis factor-alpha (TNF-alpha) and soluble TNF-alpha receptor p55 in patients with hypothyroidism and hyperthyroidism before and after normalization of thyroid function. Clin Endocrinol (Oxf) 2002; 57(4): 515-21. https://doi.org/10.1046/j.1365-2265.2002.01629.x

Sharma CK, Sharma M, Aggarwal B, Sharma V. Different Advanced Therapeutic Approaches to Treat Vitiligo. J Environ Pathol Toxicol Oncol 2015; 34(4): 321-34. https://doi.org/10.1615/JEnvironPatholToxicolOncol.2015014168

Kasumagic-Halilovic E, Prohic A, Cavaljuga S. Tumor necrosis factor-alpha in patients with alopecia areata. Indian J Dermatol 2011; 56(5): 494-6. https://doi.org/10.4103/0019-5154.87124

Lee LF, Xu B, Michie SA, Beilhack GF, Warganich T, Turley S, McDevitt HO. The role of TNF-alpha in the pathogenesis of type 1 diabetes in the nonobese diabetic mouse: analysis of dendritic cell maturation. Proc Natl Acad Sci U S A 2005; 102(44): 15995-6000. https://doi.org/10.1073/pnas.0508122102

Daniele G, Guardado Mendoza R, Winnier D, Fiorentino TV, Pengou Z, Cornell J, Andreozzi F, Jenkinson C, Cersosimo E, Federici M, Tripathy D, Folli F. The inflammatory status score including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus. Acta Diabetol 2014; 51(1): 123-31. https://doi.org/10.1007/s00592-013-0543-1

Schäkel K, Schön MP2, Ghoreschi K. Pathogenesis of psoriasis. Hautarzt 2016; 67(6): 422-31. https://doi.org/10.1007/s00105-016-3800-8

Türkcü FM, Şahin A, Cingü AK, Kaya S, Yüksel H, Cinar Y, Batmaz İ. Serum omentin, resistin and tumour necrosis factor-α levels in Behcet patients with and without ocular involvement. Graefes Arch Clin Exp Ophthalmol 2015; 253(9): 1565-8. https://doi.org/10.1007/s00417-015-3016-0

Caminero A, Comabella M, Montalban X. Tumor necrosis factor alpha (TNF-α), anti-TNF-α and demyelination revisited: an ongoing story. J Neuroimmunol 2011 May; 234(1-2): 1-6.

Scragg R. Vitamin D and Type 2 Diabetes. Are We Ready for a Prevention Trial? Diabetes 2008 Oct; 57(10): 2565-2566.

Thys-Jacobs S, Donovan D, Papadopoulos A, Sarrel P, Bilezikian JP. Vitamin and calcium dysregulation in the polycystic ovarian syndrome. Steroids 1999; 64: 430-435. https://doi.org/10.1016/S0039-128X(99)00012-4

Panidis D, Balaris C, Farmakiotis D, Rousso D, Kourtis A, Balaris V, Katsikis I, Zournatzi V, Diamanti-Kandarakis E. Serum parathyroid hormone concentrations are increased in women with polycystic ovary syndrome. Clin Chem 2005; 51: 1691-7. https://doi.org/10.1373/clinchem.2005.052761

Hahn S, Haselhorst U, Tan S, Quadbeck B, Schmidt M, Roesler S, Kimmig R, Mann K, Janssen OE. Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 2006; 114: 577-83. https://doi.org/10.1055/s-2006-948308

Kotsa K, Yavropoulou MP, Anastasiou O, Yovos JG. Role of vitamin D treatment in glucose metabolism in polycystic ovary syndrome. Fertil Steril 2009; 92: 1053-8. https://doi.org/10.1016/j.fertnstert.2008.07.1757

Rashidi B, Haghollahi F, Shariat M, Zayerii F. The effects of calcium-vitamin D and metformin on polycystic ovary syndrome: a pilot study. Taiwan J Obstet Gynecol 2009; 48: 142-7. https://doi.org/10.1016/S1028-4559(09)60275-8

Finkielstain GP, Kim MS, Sinaii N, Nishitani M, Van Ryzin C, Hill SC, Reynolds JC, Hanna RM, Merke DP. Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2012; 97(12): 4429-38. https://doi.org/10.1210/jc.2012-2102

Vitiello M, Bahtiyar G, Sacerdote A Vitamin D Deficiency/Insufficency in Patients with Non-Classic Adrenal Hyperplasia and Response of the Latter to vitamin D Replacement.Endoc Rev 110: Sun-470.

Thomas N, Kalani A, Vincent R, Luis Lam M, Bahtiyar G, Borensztein A, Quinto E, Sacerdote A. Effect of Vitamin D in a patient with classical adrenal hyperplasia due to 11-hydroxylase deficiency. J Med Cases 2013; 4, (8), 2013: 569-575.

Bahtiyar G, Sacerdote A. Management Approaches to Congenital Adrenal Hyperplasia in Adolescents and Adults; Latest Therapeutic Developments. In “Amenorrhea; publisher-Intech, Rijeka, Croatia Published on line 11-2011; published in print 12-2011.

Sacerdote A Bahtiyar G. Treatment of Congenital Adrenal Hyperplasia by Reducing Insulin Resistance and Cysticercosis Induced Polycystic Ovarian Syndrome. In Contemporary Gynecologic Practice, Prof. Atef Darwish (Ed.), ISBN: 978-953-51-1736-0, 2015 InTech, Rijeka, Croatia.

Sacerdote AS, Inoue T, Luis Lam M, Bahtiyar G. Vitamin D in the Treatment of Non-Classic 21-Hydroxylase Deficiency with Central Hypogonadism. Program: Abstracts - Orals, Poster Previews, and Posters Session: Endo Society, Boston.

Endocrine Society. "Raising low vitamin D levels lowers risk of prediabetes progressing to diabetes." ScienceDaily. ScienceDaily, 23 June 2014. .

Gezen-Ak D, Yılmazer S, Dursun E. Why vitamin D in Alzheimer's disease? The hypothesis. J Alzheimers Dis 2014; 40(2): 257-69.

Bakacak M, Serin S, Ercan O, Köstü B, Avci F, Kılınç M, Kıran H, Kiran G. Comparison of Vitamin D levels in cases with preeclampsia, eclampsia and healthy pregnant women. Int J Clin Exp Med 2015; 8(9): 16280-6.

Fan L, Tu X, Zhu Y, Zhou L, Pfeiffer T, Feltens R, Stoecker W, Zhong R. Genetic association of vitamin D receptor polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese. J Gastroenterol Hepatol 2005 Feb; 20(2): 249-55.

Ma R, Deng XL, Du GL, Li C, Xiao S, Aibibai Y, Zhu J. Active vitamin D3, 1,25-(OH)2D3, protects against macrovasculopathy in a rat model of type 2 diabetes mellitus. Genet Mol Res 2016 Jun 3; 15(2).

GK. Solar Radiation and Vitamin D: Mitigating Environmental Factors in Autoimmune Disease. Journal of Environmental and Public Health Volume 2012 (2012), Article ID 619381.

http://dx.doi.org/10.1155/2012/619381

Agmon-Levin N, Theodor E, Segal RM, Shoenfeld Y. Vitamin D in systemic and organ-specific autoimmune diseases. Clin Rev Allergy Immunol 2013 Oct; 45(2): 256-66.

Schwalfenberg ers J, Thewissen M, Peelen E, Menheere P, Tervaert JW, Damoiseaux J, Hupperts R. Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. PLoS One 2009 Aug 13; 4(8): e6635. https://doi.org/10.1371/journal.pone.0006635

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Mar. CADTH Rapid Response Reports. Vitamin D for the Treatment or Prevention of Multiple Sclerosis: A Review of the Clinical Effectiveness.

Brola W, Sobolewski P, Szczuchniak W, Góral A, Fudala M, Przybylski W, Opara J. Association of seasonal serum 25-hydroxyvitamin D levels with disability and relapses in relapsing-remitting multiple sclerosis. Eur J Clin Nutr 2016 Mar 30. https://doi.org/10.1038/ejcn.2016.51

Muscogiuri G, Mitri J2, Mathieu C, Badenhoop K, Tamer G, Orio F, Mezza T, Vieth R, Colao A, Pittas A. Mechanisms in endocrinology: vitamin D as a potential contributor in endocrine health and disease. Eur J Endocrinol 2014 Sep; 171(3): R101-10. https://doi.org/10.1530/EJE-14-0158

Kamen DL Vitamin D in lupus - new kid on the block? Bull NYU Hosp Jt Dis 2010; 68(3): 218-22.

Antico A, Tampoia M, Tozzoli R, Bizzaro N. Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature. Autoimmun Rev 2012 Dec; 12(2): 127-36.

Abou-Raya A, Abou-Raya S, Helmii M. The effect of vitamin D supplementation on inflammatory and hemostatic markers and disease activity in patients with systemic lupus erythematosus: a randomized placebo-controlled trial. J Rheumatol 2013 Mar; 40(3): 265-72.

Rashidi B, Haghollahi F, Shariat M, Zayerii F. The effects of calcium-vitamin D and metformin on polycystic ovary syndrome: a pilot study. Taiwan J Obstet Gynecol 2009; 48: 142-7. https://doi.org/10.1016/S1028-4559(09)60275-8

Vitiello M, Bahtiyar G, Sacerdote A Vitamin D Deficiency/Insufficency in Patients with Non-Classic Adrenal Hyperplasia. Endoc Rev 110: Sun-470; presented at the 94th Annual Meeting of The Endocrine Society 6-24-2012.

Thomas N, Kalani A, Vincent R, Luis Lam M, Gul Bahtiyara, Borensztein A, Quinto E, Sacerdote A. Effect of Vitamin D in a patient with classical adrenal hyperplasia due to 11-hydroxylase deficiency. J Med Cases 2013; 4, (8), 2013: 569-575.

Sacerdote A Bahtiyar G. Treatment of Congenital Adrenal Hyperplasia by Reducing Insulin Resistance and Cysticercosis Induced Polycystic Ovarian Syndrome. In Contemporary Gynecologic Practice, Prof. Atef Darwish (Ed.), ISBN: 978-953-51-1736-0, 2015 InTech, Rijeka, Croatia.

Sacerdote AS, Inoue T, Luis Lam M, Bahtiyar G. Vitamin D in the Treatment of Non-Classic 21-Hydroxylase Deficiency with Central Hypogonadism. Program: Abstracts - Orals, Poster Previews, and Posters Session: FRI 409-475-Case Reports: Adrenal Insufficiency, CAH, Cushing Syndrome and Paraganglioma (posters) Clinical Poster Board FRI 464 presented 4/1/2016 at Endo 2016, Boston, MA.

Osehobo, E., Shaw, I., and Sacerdote, A. Do Insulin Sensitizers Repair the Gene Defects in Non-Classical Congenital Adrenal Hyperplasia. Program and Abstracts, 82nd Annual Meeting of The Endocrine Society: 547, 2000 (poster presentation).

Osehobo, E. and Sacerdote, A. Aldosterone Synthase Deficiency; A Newly Described Variant of Non-Classical Congenital Adrenal Hyperplasia. Program and Abstracts, 81st Annual Meeting of The Endocrine Society, 1999 (poster presentation).

Sacerdote, A. Weight-Dependent Expression of Non-Classical Aldosterone Synthase Deficiency. And Abstracts, Endo-2002, The Endocrine Society’s 84th Annual Meeting: 599, 2002.

Kalani A, Thomas N, Sacerdote A, Bahtiyar G. Roux-en-Y gastric bypass in the treatment of non-classic congenital adrenal hyperplasia due to 11- hydroxylase deficiency. BMJ Case Rep 2013 Mar 18; 2013. https://doi.org/10.1136/bcr-2012-008416

Anwer T, Sharma M, Pillai KK, Iqbal M. Effect of Withania somnifera on insulin sensitivity in non-insulin-dependent diabetes mellitus rats. Basic Clin Pharmacol Toxicol 2008; 102(6): 498-503. https://doi.org/10.1111/j.1742-7843.2008.00223.x

Kalani A, Bahtiyar G, Sacerdote A. Ashwagandha root in the treatment of non-classical adrenal hyperplasia. BMJ Case Rep 2012 Sep 17; 2012. https://doi.org/10.1136/bcr-2012-006989

Sacerdote A, Sanchez JU, Ogbeide O, and Slabodkina L. Modification of Expression of Non-Classical Congenital Adrenal Hyperplasia by Rosiglitazone. Presented at The Endocrine Society’s 85th Annual Meeting, Friday June 20, 2003 (poster presentation).

Atabek MF, Kurtoglu S, Keskin M. Female pseudohermaphroditism due to classical 21-OH deficiency and insulin resistance in a girl with Turner Syndrome. Turk J Pediatr 2005; 47(2): 176-9.

Charmandari E, Weise M, Bornstein SR, Eisenhofer G, Keil MF, Chrousos GP, Merke DP. Children with classic congenital adrenal hyperplasia have elevated serum leptin concentrations and insulin resistance: potential clinical implications. J Clin Endocrinol Metab 2002; 87(5): 2114-20. https://doi.org/10.1210/jcem.87.5.8456

Mapas-Dimaya A, Agdere L, Bahtiyar G, Mejia J, Sacerdote A. Metformin responsive Classical salt-losing P450A2 deficiency - A case report. Endocrine Practice 2008; 14(7): 889-91. https://doi.org/10.4158/EP.14.7.889

Bahtiyar G, Weiss K, Sacerdote A. Novel endocrine disrupter effects of classic and atypical antipsychotic agents and divalproex: induction of adrenal hyperandrogenism, reversible with metformin or rosiglitazone. Endocrine Practice 2008; 13(6): 601-8. https://doi.org/10.4158/EP.13.6.601

Lundqvist J, Wikvall K, Norlin M. Vitamin D-mediated regulation of CYP21A2 transcription - a novel mechanism for vitamin D action. Biochim Biophys Acta 2012; 1820(10): 1553-1559. https://doi.org/10.1016/j.bbagen.2012.04.017

Chen W, Kim MS, Shanbhag S, Arai A, VanRyzin C, McDonnell NB, Merke DP. The phenotypic spectrum of contiguous deletion of CYP21A2 and tenascin XB: quadricuspid aortic valve and other midline defects. Am J Med Genet A 2009; 149A(12): 2803-8.

Merke DP, Chen W, Rachel R, Xu Z, Van Ryzin C, Sachdev V, Hannoush H, Shanbhag SM, Acevedo AT, Nishitani M, Arai AE, McDonnell NB. Tenascin-X haploinsufficiency associated with Ehlers-Danlos Syndrome in patients with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2013; 98(2): E379-E387.

Sacerdote, A. and Li, Y. Adrenal Hyperandrogenemia is Associated with Non-Rheumatic Cardiac Abnormalities. Program and Abstracts, 79th Annual Meeting of The Endocrine Society: 310, 1997 (poster presentation).

El-Masri MA, Clark BJ, Qazzaz HM, Valdes R Jr. Human adrenal cells in culture produce both ouabain-like and dihydroouabain-like factors. Clin Chem 2002 Oct; 48(10): 1720-30.

Grossman AB. Addison's disease; primary or chronic adrenocortical insufficiency. , MERCK MANUAL Professional Version. http://www.merckmanuals.com/professional/ endocrine-and-metabolic-disorders/adrenal-disorders/addison-disease

Betterle C, Lazzarotto F, Presotto F. Autoimmune polyglandular syndrome Type 2: the tip of an iceberg? Clin Exp Immunol 2004; 137(2): 225-233. https://doi.org/10.1111/j.1365-2249.2004.02561.x

Winqvist O, Gustafsson J, Rorsman F, Karlsson FA, Kämpe O. Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison's disease. J Clin Invest 1993 Nov; 92(5): 2377-2385.

Tattersall. RB Hypoadrenia or "a bit of Addison's disease". Med Hist. 1999; 43(4): 450-467.

Tomczynska M, Bijak M, Saluk.J. Metformin - The drug for the treatment of autoimmune diseases; a new use of a known anti-diabetic drug. Metformin - The Drug for the Treatment of Autoimmune Diseases; A New Use of a Known Anti-Diabetic Drug. Curr Top Med Chem 2016; 16(19): 2223-30. https://doi.org/10.2174/1568026616666160216152324

Negrotto L, Farez MF, Correale J. Immunologic effects of metformin and pioglitazone treatment on metabolic syndrome and multiple sclerosis. JAMA Neurol 2016; 73(5): 520-8. https://doi.org/10.1001/jamaneurol.2015.4807

Bubna AK. Metformin - For the dermatologist. Indian J Pharmacol 2016 Jan-Feb; 48(1): 4-10.

Wang H, Li T, Chen S, Gu Y, Ye S. Neutrophil extracellular trap mitochondrial DNA and its autoantibody in systemic lupus erythematosus and a proof-of concept trial of metformin. Arthritis Rheumatol 2015; 67(12): 3190-200. https://doi.org/10.1002/art.39296

Krysiak R, Szkrobka W, Okopien B. The effect of metformin on hypothalamic-pituitary-thyroid axis activity in women with interferon-induced hypothyroidism: A Pilot Study. Exp Clin Endocrinol Diabetes 2016; 124(2): 71-6. https://doi.org/10.1055/s-0035-1565207

Wada K, Kamisaki Y. [Anti-inflammatory effect of PPAR gamma agonists: basics and clinical applications]. Nihon Rinsho 2010; 68(2): 278-83.

Rousseaux C, Desreumaux P. The peroxisome-proliferator-activated gamma receptor and chronic inflammatory bowel disease (PPARgamma and IBD). J Soc Biol 2006; 200(2): 121-31. https://doi.org/10.1051/jbio:2006015

Marder W, Khalatbari S, Myles JD, Hench R, Lustig S, Yalavarthi S, Parameswaran A, Brook RD, Kaplan MJ. The peroxisome proliferator activated receptor-γ pioglitazone improves vascular function and decreases disease activity in patients with rheumatoid arthritis. J Am Heart Assoc 2013 Nov 19; 2(6).

Sparks JA, Halperin F, Karlson JC1, Karlson EW1, Bermas BL. Impact of bariatric surgery on patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) 2015; 67(12): 1619-26. https://doi.org/10.1002/acr.22629

Jensen P, Christensen R, Zachariae C, Geiker NR, Schaadt BK, Stender S, Hansen PR, Astrup A, Skov L. Long-term effects of weight reduction on the severity of psoriasis in a cohort derived from a randomized trial: a prospective observational follow-up study. Am J Clin Nutr 2016; 104(2): 259-65. https://doi.org/10.3945/ajcn.115.125849

Kumar G, Srivastava A, Sharma SK, Rao TD, Gupta YK. Efficacy & safety evaluation of Ayurvedic treatment (Ashwagandha powder & Sidh Makardhwaj) in rheumatoid arthritis patients: a pilot prospective study. Indian J Med Res 2015; 141(1): 100-6. https://doi.org/10.4103/0971-5916.154510

Bright JJ. Curcumin and autoimmune disease. Adv Exp Med Biol 2007; 595: 425-51. https://doi.org/10.1007/978-0-387-46401-5_19

Balakrishnan A, Satyamoorthy K, Joshi MB. Role of IL-6/JAK/STAT pathway in inducing vascular insulin resistance. Mol Cytogenet 2014; 7(Suppl 1): P96.

Laura J. McCreight, Clifford J. Bailey, and Ewan R. Pearson. Metformin and the gastrointestinal tract. Diabetologia 2016; 59: 426-435. https://doi.org/10.1007/s00125-015-3844-9

Christine M. Peat, Susan C. Kleiman, Cynthia M. Bulik, and Ian M. Carroll. The intestinal microbiome in bariatric surgery patients. Eur Eat Disord Rev 2015; 23(6): 496-503. https://doi.org/10.1002/erv.2400